Loading…
Sudeep Pharma (SUDEEPPHRM)₹1,210−0.14%Pharmaceuticals
At the end of the Sep 2026 quarter, Sudeep Pharma's shareholders were: promoters 76.15%, FIIs 2.91%, DIIs 14.07%, public 6.87%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 40,455 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|
| Promoters | 76.15% | 76.15% | 76.15% | 76.15% |
| FIIs | 1.66% | 1.54% | 1.80% | 2.91% |
| DIIs | 17.60% | 18.12% | 15.65% | 14.07% |
| Public | 4.59% | 4.19% | 6.40% | 6.87% |
| Promoter shares pledged | — | — | — | 0.00% |
| Number of shareholders | 43,588 | 36,494 | 35,686 | 40,455 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Riva Resources Private Limited | Promoter | 40.38% | 0.00 |
| Bhayani Sujit Jaysukh | Promoter | 21.13% | 0.00 |
| Sujeet Jaysukh Bhayani Huf | Promoter | 5.75% | 0.00 |
| Shanil Sujit Bhayani | Promoter | 4.49% | 0.00 |
| Avani Sujeet Bhayani | Promoter | 4.46% | 0.00 |
| Sbi Healthcare Opportunities Fund | DII | 2.86% | +1.65 |
| Nuvama Crossover Opportunities Fund - Series Iii B | DII | 2.13% | 0.00 |
| Axis Mutual Fund Trustee Limited A/C Axis Mutual Fund A/C Axis Small Cap Fund | DII | 1.82% | −0.04 |
| Mukul Mahavir Agrawal | Public | 1.32% | 0.00 |
| Nuvama Crossover Opportunities Fund - Series Iii | DII | 1.10% | −1.83 |
| Nuvama Crossover Opportunities Fund - Series Iii A | DII | 1.09% | −1.50 |
Promoters held 76.15% of Sudeep Pharma at the end of the Sep 2026 quarter.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 2.91% (up 1.11 percentage points from 1.80% a quarter earlier) and domestic institutions (DIIs) held 14.07% (down 1.58 percentage points from 15.65% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Sudeep Pharma had 40,455 shareholders at the end of the Sep 2026 quarter.
Sbi Healthcare Opportunities Fund (DII) held 2.86% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.